NorthWest Biotherapeutics Inc (NWBO)

[BWIS]

I asked someone to call and finally just called myself. I'm not a huge investor so I really don't like to waste their time. No answer at Innes number so I called Les #. From memory the following. No quotes.

I opened by asking him when shareholders would hear something about status of trial. He gave no responses or dates for information update.

Sounds like the haven't finalized the SAP with regulator updates, 1 or more. They're still waiting or deciding whether to implement, or in the process of implementing any suggestions/changes they've received.

I asked if they would have multiple SAPs for each different RA depending on the changes each might suggest. He indicated there'd be only 1 final SAP.

He mentioned there's a new policy down at the FDA they're waiting to have SOC from other trials to be used against our treatment patients to help the statistical significance. And that they're waiting for the FDA to implement that new policy. And this new policy might be useful to NWBO.

I asked him how many are alive and he wouldn't say. I mentioned that they told us a few years ago how many were alive so why can't we know now. He wouldn't say. To be clear I was asking for a PR release with some encouraging info, not to tell me in isolation.

I told him I thought LLiau said the FDA required us to have crossover. He said no that wasn't an FDA decision.

The problem I have with this is:
If mgmt believes we need a change in FDA policy to improve the likeliness of success. Nwbo is something less confident without that change despite their ravings about not seeing life longevity in a trial like this before. These 2 things seem to be at odds with each other. I've felt for a long time that they are afraid to complete and submit the trial while others here seem to argue.

I'm submitting this without review so there might be some mistakes. I can only post one message a day so asking me questions won't do any good.